Collaboration and Standardization: Key Themes from the DIA RSIDM Conference in Washington

Our CEO Heiner Oberkampf represented our organization at the DIA Regulatory Submissions, Information, and Document Management (RSIDM) Conference in Washington, participating as a speaker in the Session “The Next Frontier in Regulatory Submissions – Powering Industry Growth with Structured Data to Deliver Value Through Connected Global Use Cases.” together with other industry leaders.
View the session details here.

‍

The conference once again proved to be an outstanding platform for collaboration and knowledge exchange, bringing together experts in regulatory, safety, and supply domains to explore how structured data and global standards can transform the pharmaceutical industry.

‍

A key takeaway from this year’s discussions: Collaboration is king. To fully realize the benefits of data standards such as ISO IDMP, the industry must continue to work together across regions and organizations. Significant momentum is building through initiatives like the Global IDMP Working Group (GIDWG), the IDMP Ontology Project led by the Pistoia Alliance, and the PRISM initiative — all supported by the tremendous progress of the European Medicines Agency’s Product Management Service (PMS), now leveraged within the European Shortage Monitoring Platform.

‍

Many sessions also emphasized the growing importance of data quality and governance. As several speakers highlighted, these must be embedded into the core business strategy of pharmaceutical companies to justify and sustain the necessary investments in high-quality, structured regulatory data.

‍

The message from Washington was clear: through collaboration, data standardization, and strong governance, the global pharmaceutical ecosystem can move closer to seamless, connected, and value-driven regulatory processes.